N. Parker
1 Papers
36 Citations
N. Parker is an academic researcher. The author has contributed to research in topics: Transplantation. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy.
Henry Miles Prince,John Bashford,D. Wall,Danny Rischin,N. Parker,G. C. Toner,John F. Seymour,D. Blakey,David N. Haylock,Paul J. Simmons,Prudence A. Francis,Max Wolf,EH Januszewicz,G Richardson,J. Scarlett,P. Briggs +15 more
TL;DR: It is demonstrated that Isolex 300i CD34-selected cells are capable of supporting multiple cycles of HDT, but sufficient CD34+ cells are unable to acquire sufficient to perform this processing in 45% of patients and further improvements in yield are required to overcome the modest delay in neutrophil and platelet recovery.
36